LifeStance Health completed an offering of 22,250,000 common shares sold by selling stockholders and agreed to repurchase 2,000,000 of those shares from the underwriter at the same per-share price. The company received no offering proceeds, so the transaction was not a capital-raising event for LifeStance Health.

Key Highlights

  • LifeStance Health agreed to buy 2,000,000 shares from Barclays Capital at the same price paid by the underwriter.
  • Barclays Capital served as underwriter, while Barclays Capital received no compensation for the repurchased shares.
  • LifeStance Health completed an offering of 22,250,000 common shares sold by selling stockholders.

LifeStance Health Group, Inc. (NASDAQ: LFST) completed an underwritten offering of 22,250,000 common shares sold by selling stockholders. LifeStance Health received no proceeds from the transaction.

22,250,000 Shares Sold by Stockholders

The shares are common stock with a Par Value of $0.01 per share, and the offering was conducted under the company’s registration statement filed on May 21, 2024. LifeStance Health also agreed to purchase 2,000,000 shares from Barclays Capital. The company agreed to pay the same per-share price that Barclays Capital paid the selling stockholders, and the underwriter received no compensation for those repurchased shares. The offering closed on September 11, 2026. Ropes & Gray LLP issued an opinion concerning the shares sold, and Ryan McGroarty signed the company’s report as chief financial officer.